Topics

Procyrion Raises $30M to Support Clinical Trials of its Percutaneous Blood Pump Device

09:44 EDT 9 Jul 2019 | HIT Consultants

Procyrion, Inc., a Houston-based medical device firm developing the first catheter-deployed, intra-aortic pump initially for use in cardiorenal syndrome patients announced it has raised $30 million in Series D funding led by Bluebird Ventures. The round also includes participation from existing investors Fannin Partners, Scientific Health Development, the State of Texas, and an undisclosed strategic ... Read More

Original Article: Procyrion Raises $30M to Support Clinical Trials of its Percutaneous Blood Pump Device

NEXT ARTICLE

More From BioPortfolio on "Procyrion Raises $30M to Support Clinical Trials of its Percutaneous Blood Pump Device"

Quick Search

Relevant Topic

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...